Literature DB >> 20011698

TLR4 in Chlamydia trachomatis infections: knockout mice, STD patients and women with tubal factor subfertility.

J E den Hartog1, J M Lyons, S Ouburg, J S A Fennema, H J C de Vries, C A Bruggeman, J I Ito, A S Peña, J A Land, S A Morré.   

Abstract

Chlamydia trachomatis is the most prevalent sexually transmitted bacterium in the world with almost 100 million new cases each year, some of which will develop tubal pathology. Clear differences in its clinical course of infections have been observed, and recently it has been shown that 40% is based on host genetic factors. We used an integrated approach based on infection of Toll-like receptor 4 (TLR4) knockout mice and immunogenetic analysis of female sexually transmitted disease (STD) patients (susceptibility) and women with C. trachomatis-associated tubal factor subfertility (severity). The results in TLR4 knockout mice suggest that the protection against reinfection is more solid in normal as compared to the TLR4-deficient mice. In humans the functional TLR4 single nucleotide polymorphism studied was not involved in the susceptibility to infection. However, C. trachomatis immunoglobulin (Ig) G-positive subfertile women with tubal pathology were more than twice as likely to be carriers of the mutant TLR4 +896 G allele as compared to those without tubal pathology; however this observation did not reach statistical significance. In conclusion, both the murine model and the human immunogenetics studies show a slight effect upon TLR4 deficiency in the severity of infection but not in the susceptibility to infection. Copyright 2009 Prous Science, S.A.U. or its licensors. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20011698

Source DB:  PubMed          Journal:  Drugs Today (Barc)        ISSN: 1699-3993            Impact factor:   2.245


  11 in total

1.  Murine MicroRNA-214 regulates intracellular adhesion molecule (ICAM1) gene expression in genital Chlamydia muridarum infection.

Authors:  Tanvi Arkatkar; Rishein Gupta; Weidang Li; Jieh-Juen Yu; Shradha Wali; M Neal Guentzel; James P Chambers; Lane K Christenson; Bernard P Arulanandam
Journal:  Immunology       Date:  2015-06-29       Impact factor: 7.397

2.  Variants in toll-like receptor 1 and 4 genes are associated with Chlamydia trachomatis among women with pelvic inflammatory disease.

Authors:  Brandie D Taylor; Toni Darville; Robert E Ferrell; Candace M Kammerer; Roberta B Ness; Catherine L Haggerty
Journal:  J Infect Dis       Date:  2012-01-11       Impact factor: 5.226

3.  Host Polymorphisms in TLR9 and IL10 Are Associated With the Outcomes of Experimental Haemophilus ducreyi Infection in Human Volunteers.

Authors:  Martin Singer; Wei Li; Servaas A Morré; Sander Ouburg; Stanley M Spinola
Journal:  J Infect Dis       Date:  2016-04-27       Impact factor: 5.226

4.  TLR2, TLR4 and TLR9 genotypes and haplotypes in the susceptibility to and clinical course of Chlamydia trachomatis infections in Dutch women.

Authors:  Stephan P Verweij; Ouafae Karimi; Jolein Pleijster; Joseph M Lyons; Henry J C de Vries; Jolande A Land; Servaas A Morré; Sander Ouburg
Journal:  Pathog Dis       Date:  2015-11-13       Impact factor: 3.166

5.  CD4+ T cell expression of MyD88 is essential for normal resolution of Chlamydia muridarum genital tract infection.

Authors:  Lauren C Frazer; Jeanne E Sullivan; Matthew A Zurenski; Margaret Mintus; Tammy E Tomasak; Daniel Prantner; Uma M Nagarajan; Toni Darville
Journal:  J Immunol       Date:  2013-09-13       Impact factor: 5.422

6.  CpG DNA analysis of bacterial STDs.

Authors:  Martin Singer; Dewi J de Waaij; Servaas A Morré; Sander Ouburg
Journal:  BMC Infect Dis       Date:  2015-07-16       Impact factor: 3.090

7.  The Potential Role for Host Genetic Profiling in Screening for Chlamydia-Associated Tubal Factor Infertility (TFI)-New Perspectives.

Authors:  Jelena Malogajski; Ivan Branković; Jolande A Land; Pierre P M Thomas; Servaas A Morré; Elena Ambrosino
Journal:  Genes (Basel)       Date:  2019-05-28       Impact factor: 4.096

8.  Translational potential into health care of basic genomic and genetic findings for human immunodeficiency virus, Chlamydia trachomatis, and human papilloma virus.

Authors:  Jelena Malogajski; Ivan Brankovic; Stephan P Verweij; Elena Ambrosino; Michiel A van Agtmael; Angela Brand; Sander Ouburg; Servaas A Morré
Journal:  Biomed Res Int       Date:  2013-05-23       Impact factor: 3.411

Review 9.  Trachoma: protective and pathogenic ocular immune responses to Chlamydia trachomatis.

Authors:  Victor H Hu; Martin J Holland; Matthew J Burton
Journal:  PLoS Negl Trop Dis       Date:  2013-02-14

10.  TRAIL-R1 is a negative regulator of pro-inflammatory responses and modulates long-term sequelae resulting from Chlamydia trachomatis infections in humans.

Authors:  Mufadhal Al-Kuhlani; James Rothschild; James Rothchild; Sukumar Pal; Luis M de la Maza; Sander Ouburg; Servaas A Morré; Deborah Dean; David M Ojcius
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.